| dc.date.accessioned | 2023-03-06T07:33:03Z | |
| dc.date.available | 2023-03-06T07:33:03Z | |
| dc.date.issued | 2022 | |
| dc.identifier.citation | Eur J Rheumatol. 2022 Oct;9(4):206-211. doi: 10.5152/eurjrheum.2022.21153. | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12619/100525 | |
| dc.relation.isversionof | 10.5152/eurjrheum.2022.21153 | |
| dc.relation.isversionof | 10.5152/eurjrheum.2022.21153 | |
| dc.title | The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database | |
| dc.relation.journal | Eur J Rheumatol | |
| dc.identifier.doi | 10.5152/eurjrheum.2022.21153 | |
| dc.contributor.author | Alpay Kanıtez N | |
| dc.contributor.author | Alpay Kanıtez N | |
| dc.contributor.author | Kiraz S | |
| dc.contributor.author | Dalkılıç E | |
| dc.contributor.author | Kimyon G | |
| dc.contributor.author | Mercan R | |
| dc.contributor.author | Karadağ Ö | |
| dc.contributor.author | Bes C |
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||